Ipronidazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101664This classification denotes an antiprotozoal agent with the molecular formula C7H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 045BU63E23, chemically known as 1h-imidazole, 2-isopropyl-1-methyl-5-nitro- but generally known as ipronidazole, which bears US NIH Compound Identifier 26951. European Medicines Agency schedules Ipronidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08284MIG. The term IPRONIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). IPRONIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ipronidazole under HS 29332990 and SITC 51573. As of Q4 2014, IPRONIDAZOLE remains the US FDA Preferred Term for this commodity. Ipronidazole bears US NLM identifiers UMLS ID C0022060 and NCI Concept Code C76423. SMILES: O[N](=O)C1N(C(NC1)C(C)C)C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.